key: cord-0333860-mkdu2s47
authors: Kenney, Devin J.; O’Connell, Aoife K.; Turcinovic, Jacquelyn; Montanaro, Paige; Hekman, Ryan M.; Tamura, Tomokazu; Berneshawi, Andrew R.; Cafiero, Thomas R.; Abdullatif, Salam Al; Blum, Benjamin; Goldstein, Stanley I.; Heller, Brigitte L.; Gertje, Hans P.; Bullitt, Esther; Trachtenberg, Alexander J.; Chavez, Elizabeth; Sheikh, Amira; Kurnick, Susanna; Grosz, Kyle; Bosmann, Markus; Ericsson, Maria; Huber, Bertrand R.; Saeed, Mohsan; Balazs, Alejandro B.; Francis, Kevin P.; Klose, Alexander; Paragas, Neal; Campbell, Joshua D.; Connor, John H.; Emili, Andrew; Crossland, Nicholas A.; Ploss, Alexander; Douam, Florian
title: Macrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
date: 2021-07-19
journal: bioRxiv
DOI: 10.1101/2021.07.17.452554
sha: a9ea254c09720b8fbabdd50074951b01d6ac098e
doc_id: 333860
cord_uid: mkdu2s47

The majority of SARS-CoV-2 infections among healthy individuals result in asymptomatic to mild disease. However, the immunological mechanisms defining effective lung tissue protection from SARS-CoV-2 infection remain elusive. Unlike mice solely engrafted with human fetal lung xenograft (fLX), mice co-engrafted with fLX and a myeloid-enhanced human immune system (HNFL mice) are protected against SARS-CoV-2 infection, severe inflammation, and histopathology. Effective control of viral infection in HNFL mice associated with significant macrophage infiltration, and the induction of a potent macrophage-mediated interferon response. The pronounced upregulation of the USP18-ISG15 axis (a negative regulator of IFN responses), by macrophages was unique to HNFL mice and represented a prominent correlate of reduced inflammation and histopathology. Altogether, our work shed light on unique cellular and molecular correlates of lung tissue protection during SARS-CoV-2 infection, and underscores macrophage IFN responses as prime targets for developing immunotherapies against coronavirus respiratory diseases. HIGHLIGHTS Mice engrafted with human fetal lung xenografts (fLX-mice) are highly susceptible to SARS-CoV-2. Co-engraftment with a human myeloid-enriched immune system protected fLX-mice against infection. Tissue protection was defined by a potent and well-balanced antiviral response mediated by infiltrating macrophages. Protective IFN response was dominated by the upregulation of the USP18-ISG15 axis.

• Mice engrafted with human fetal lung xenografts (fLX-mice) are highly susceptible to SARS-49

CoV-2. 50

• Co-engraftment with a human myeloid-enriched immune system protected fLX-mice against 51 infection. 52

• Tissue protection was defined by a potent and well-balanced antiviral response mediated by 53 infiltrating macrophages. 54

• Protective IFN response was dominated by the upregulation of the USP18-ISG15 axis. Figure S2N ,P), although at 7DPI it was mainly found in necrotic 228 debris within the airspaces (Figure 1K; Figure S2O ). Infection appeared to be cleared at 7DPI 229 for the 10 4 PFU dose (Figure S2K,L) . These findings were supported by 5-color fluorescent 230 imaging (DAPI, SARS-CoV-2 Spike, CD31, CD61, CD68) ( Figure 1F ,G,I,J,L,M), which also 231 showed an increase of platelet rich thrombi in infected fLX at 7DPI, a feature consistent with 232 previous studies in human and non-human primates (Aid et al., 2020; Mackman et al., 2020) . 233

RT-qPCR quantification of viral RNA (E gene) was consistent with immunohistochemistry 234 (IHC) findings (Figure 1N-O) . Although RT-qPCR suggested that low levels of viral RNA were 235 present in contralateral fLX, SARS-CoV-2 N immunoreactivity was never observed in contralateral 236 fLX ( Figure S2Q ). Quantification of infectious viral particles at 2DPI and 7DPI supported evidence 237 of productive infection in fLX, with detection of infectious viral particles at both time points in 238 infected fLX. No infectious viral particles were detected in contralateral fLX ( Figure 1P ) 239

suggesting that limited amount of viral RNA but not infectious viral particles may transfer between 240 fLX through the blood. However, no viral RNA was detected in the peripheral blood at any time 241 point ( Figure S2R ) further strengthening evidence that the amount of circulating viral RNA 242 transferring between fLX is probably very low. 243

We found a positive non-linear regression between viral load and PFU in infected fLX 244 (R 2 =0.675) (Figure 1Q ). Using these data, we identified that viral loads in excess of a threshold 245 of 10 7 RNA copies/mg tissue (i.e. productive infection threshold or PIT) were indicative of 246 productive infection. 247

To further confirm evidence of productive infection in NRG-L fLX, we performed planar 248 and 3D in vivo bioluminescence imaging on NRG-L mice inoculated with a recombinant SARS-249

CoV-2 expressing NanoLuc luciferase (Xie et al., 2020) . The NanoLuc bioluminescent signal was 250 readily detectable in inoculated fLX mice as early as 2DPI (Figure 1R To capture the heterogeneity and severity of histologic phenotypes observed in SARS-CoV-2 259 infected fLX, we developed a semi-quantitative ordinal scoring (see methods). The mean 260 cumulative histologic score in animals inoculated with 10 6 PFU was 1.76-fold higher at 2 DPI and 261 2.22-fold higher at 7 DPI compared to those inoculated with 10 4 PFU, indicating a positive 262 correlation with the viral load and SARS-CoV-2 N positivity. (Figure 2A ; Figure S3A ). Therefore, 263

we elected to pursue all subsequent analysis of SARS-CoV-2 infected fLX using the 10 6 dose, 264

which when compared to naïve fLX, resulted in an increasing histopathological score over time 265 ( Figure 2B; Figure S3B ). Notably, neutrophil influx, intra-airspace necrosis, capillary fibrin 266 thrombi, and presence of syncytial cells were the most significant independent observations that 267 contributed to the increased cumulative score. Of note, tissue integrity and architecture between 268 naïve and contralateral fLX was similar. Therefore, this histopathological analysis, both naïve 269 and fLX were pooled together to define the histopathological baseline ( Figure 2B (Figure 2E, I) . Similar features to those were observed at 7DPI, but airspaces were more 280 frequently filled with abundant necrotic cellular debris (Figure 2J) , and in one fLX, a distinctive 281 hyaline membrane lining pneumocytes could also be observed ( Figure 2K) . 282

Transgenic C57BL/6 mice expressing human ACE2 under the control of the cytokeratine-283 18 promoter (K18-hACE2) have been reported to be highly susceptible to SARS-CoV-2 (Winkler 284 et al., 2020) . Inoculation of K18-hACE2 mice with 10 6 PFU of SARS-CoV-2 using the same viral 285 stock resulted in multifocal interstitial pneumonia and abundant SARS-CoV-2 S antigen within 286 AT1 and AT2 cells at 2 DPI and increased interstitial histiocyte and lymphocyte infiltrates at 7DPI 287 ( Figure S3C-N) . Although we have recently confirmed that infection with the same viral stock of 288 SARS-CoV-2 was lethal in this model (Carossino et al., 2021) , we were unable to observe in this 289 model the diversity and severity of lung histopathological features observed in inoculated fLX, 290

including syncytia, necrosis, microthrombi, and hemorrhage. Taken together, our findings indicate 291 that fLX inoculated with SARS-CoV-2 more faithfully recapitulate several features of diffuse 292 alveolar damage (DAD) as described in cases of severe COVID-19 disease. 293

Ultrastructural analysis of fLX infected with 10 6 PFU supported our virological and 294 histopathological findings. Virus particles were observed within AT2 pneumocytes at various 295 stages of maturation and were often confined to double membrane bound vesicles (DMVs), with 296 morphology and particle size consistent with previously described coronaviruses (range 80-297 130nm in diameter) (Laue et al., 2021) (Figure 2L-N) . Potential single-particle budding events 298 ( Figure S4A ) and viral particle phagocytosis by macrophages ( Figure 2O ) were observed. At 299 7DPI, airspaces were filled with abundant necrotic cellular debris including lamellar bodies, Figure S4E ). 304

Faint Spike protein coronal surface projections were sometimes visible within DMVs ( Figure 2T) . 305

Blood vessels also contained aggregates of platelets ( Figure 2U ) with several small to 306 intermediate-sized arteries occasionally occluded by fibrin thrombi (Figure S4F) . Altogether, our 307 data demonstrate that SARS-CoV-2 infection of NRG-L mice is associated with the development 308 of cellular and histopathological features that resemble those observed in the lungs of severe 309 COVID-19 patients. of SARS-CoV-2 in the human lung, we examined the transcriptomic and proteomic signatures 315 associated with persistent infection and histopathology. mRNA sequencing yielded mostly human 316 mRNAs; samples with less than 15 million human-aligning reads and/or less than 75% human 317 reads were excluded from further analysis (n=3 out of 19) ( Figure S5A ). As expected, viral RNA 318 was detectable in all inoculated fLX but was more prominently detected in 2DPI samples (Figure 319 signals or pathogen-associated molecular motifs (i.e. viral RNA) to contralateral grafts via the 331 peripheral blood. Further, chemokine mRNAs were not upregulated in contralateral grafts (Figure 332 3C), underscoring a link between viral infection, high chemokine expression, persistent 333 inflammation and histopathology. A QIAGEN Ingenuity Pathway Analysis (IPA) supported 334 evidence of prolonged inflammation in inoculated but not in contralateral NRG-L fLX (Figure 3E) , 335 as many processes involving pro-inflammatory cytokines and mediators (IL-2, IL-7, IL-17, 336 chemokine signaling, T-cell signaling pathways, etc.) were only observed in inoculated fLX. 337

Notably, IPA suggested a key role of the human resident hematopoietic compartment in these 338 inflammatory processes. 339

Proteomic analysis were consistent with our transcriptomic findings, and revealed the 340 induction of a canonical, robust type I IFN response at 2DPI which resolved at 7DPI ( As we hypothesized that a major cause of the inability of fLX to effectively control infection was 359 the lack of critical hematopoietic effectors able to strengthen and balance antiviral responses, we 360 decided to investigate whether a mature human hematopoietic compartment in fLX would protect 361 fLX from infection. Although human hematopoietic stem cell (HSC) engraftment in NRG mice has 362 been shown to result in robust human lymphoid chimerism, myeloid lineages and NK cell 363 frequencies remain low, which impairs antiviral innate immune responses and T-cell mediated 364

immunity (Douam et al., 2018) . Addressing these caveats, we previously reported that NRG mice 365 with a targeted disruption of fetal liver kinase 2 expression (NRG-Flk2 -/or NRGF) display a 366 selective expansion of the human myeloid and NK cell compartment upon adenovirus-mediated 367 delivery of human FMS-related receptor tyrosine kinase 3 ligand (hFlt3LG), the ligand of Flk2 368 (Douam et al., 2018) . We found that these mice were able to mount enhanced innate and T-cell 369 responses against the yellow fever vaccine strain 17D (Douam et al., 2018) . Therefore, we aimed 370 here to engraft NRGF mice with pairs of fLX similarly to NRG mice, prior to injection of allogeneic 371 human hematopoietic stem cells 3-5 weeks post fLX engraftment ( Figure 4A) . 372

Twelve to sixteen weeks post HSC engraftment, we injected mice with 2x10 11 copies of 373 adeno-associated virus (AAV) encoding for hFlt3LG to promote expansion of the myeloid 374 compartment (yielding HIS-NRGF/Flt3LG-L, or HNFL), and analyzed the human hematopoietic 375 reconstitution of fLX 14 days post AAV injection. Using flow cytometry, we found that frequencies 376 of human CD45 + were significantly increased in fLX of HNFL in comparison to NRG-L mice 377 Flk2 expression, the mouse myeloid compartment in fLX of HNFL was reduced (15.75%) over 386 NRG-L mice, and was mainly composed of monocytes, mast cells and macrophages subsets 387 ( Figure 4C ,G,I). We identified alveolar macrophages (1.76%) as the sole human myeloid subset 388 in fLX beyond lymphoid subsets ( Figure 4F; Figure S7A ). We found that the presence of 389 macrophages was a defining characteristic of the fLX HNFL when compared to NRG-L mice, as 390 back-to-back proteomic analysis of naïve fLX between NRG-L and HNFL showed significant 391 upregulation of many macrophage markers such as HCK, SLC9A9, and CD163 ( Figure S7B ). 392

Consistently, quantification of CD68+ cells using 6-color imaging and quantitative image analysis 393 confirmed the significantly higher engraftment of fLX for CD68 + macrophages in HNFL mice 394 ( Figure S7C ). The majority of CD68 + cells were located within airspaces, but were also observed 395 in the interstitium (Figure 5A-C) . Altogether, our findings show that the HNFL model represents 396 a promising platform to explore the role of the human myeloid compartment in regulating SARS-397

CoV-2 infection in the human lung. 398 399 fLX in HNFL mice are protected from SARS-CoV-2 infection. 400

In striking contrast to NRG-L mice, inoculation of HNFL fLX with SARS-CoV-2 (10 6 PFU) one-401

week post AAV-Flt3LG injection resulted in the absence of productive infection, as assessed by 402 low to no SARS-CoV-2 Spike immunoreactivity (Figure 5A -I) and by the detection of viral RNA 403 copies per mg of tissues significantly below PIT ( Figure 5J) . Importantly, the lack of Flk2 404 expression did not affect fLX susceptibility to infection (Figure S7D) , underscoring that the 405 protective phenotype was not mediated by a reduced mouse myeloid compartment. Despite very 406 limited infection events, spike antigen distribution in HNFL mirrored that observed with NRG-L 407 mice, confined to the cytoplasm of viable-looking AT2 pneumocytes and bronchiole epithelium 408 ( Figure 5E,H) , but with little to no discernible cytopathic effect or neighboring intra-airspace 409

Consistently, cumulative histology scores were significantly decreased in HNFL mice at 411 2DPI (p=0.01) and 7DPI (p=0.0002) when compared to NRG-L ( Figure 5K; Figure S7E ). HNFL 412 fLX mice showed decreased syncytial cells and intra-airway necrosis at 2DPI and 7DPI, 413

respectively when compared to NRG-L fLX. Hemorrhage and influx of neutrophils were also 414 significantly decreased at both 2DPI and 7DPI for HNFL fLX compared to NRG-L fLX. 415

Taken together, these findings suggest that human hematopoietic engraftment in HNFL 416 may promote an effective host response in fLX that prevents the establishment of persistent 417 SARS-CoV-2 infection, and protects tissues from diffuse alveolar damage. 418

Human CD45 + frequency ( Figure 5L ) and human T cell, B cell, and CD56 + normalized cell counts 

Finally, we used scRNAseq to define which cellular compartment(s) mediate this potent ISG 462 response associated with tissue protection. scRNAseq analysis confirmed significant 463 hematopoietic infiltration in HNFL fLX at 2DPI (78.89% human cell vs. 48.41% in naïve fLX) and 464

progressive resorption of such infiltration by 7DPI (68.52% human cells) (Figure 6A -E; 465

Supplemental Item 1). The major subsets mediating hematopoietic expansion in infected fLX 466 were macrophages (Naïve, 1.76%; 2DPI, 18.39%; 7DPI, 20.49%) and B-cells (Naïve, 0%; 2DPI 467 7.24%; 7DPI, 3.31%) ( Figure 6F ). Consistent with our findings above, the size of the AT2 sub-468 compartment within the epithelial compartment was reduced at 2DPI (12.7%) but restored at 7DPI 469 

When analyzing the cellular distribution of top upregulated ISGs from our proteomic and 489 transcriptomic HNFL datasets at 2DPI, we found that activated macrophages ubiquitously 490 expressed every single ISG examined (n=15) (Figure 6J Immunodeficient mice engrafted with fLX have been previously reported to be highly 512 permissive to coronavirus infection (Wahl et al., 2021) . Such in vivo platforms carry substantial 513 advantages over other in vivo models (including humans) in a way that enables investigations into 514 coronavirus infection within a human lung environment over time and in controlled experimental 515 settings. However, given our common understanding that the quality of immune responses during 516 SARS-CoV-2 infection defines disease outcome, the lack of significant human hematopoietic 517 reconstitution in these models has precluded their use for investigating human immune responses 518 against coronavirus infection. Here, we report that NRG-L mice singly engrafted with fLX are 519 highly susceptible to SARS-CoV-2 infection. Inoculated fLX were prone to extensive inflammation, 520 which associated with severe histopathological manifestations of disease. In sharp contrast, co-521 engraftment of fLX and human HSC in HNFL mice resulted in protection against SARS-CoV-2 522 infection, as well as limited inflammation and histopathology. 523

Protection associated with the induction of a superior ISG response in HNFL mice as 524 compared to NRG-L mice, which was dominated by the upregulation of the USP18-ISG15 axis -525 a unique feature of inoculated HNFL fLX. USP18-ISG15 upregulation correlated with the absence 526 of prolonged inflammation and severe histopathology, consistent with its role as a negative 527 regulator of antiviral responses. Inoculation of HNFL fLX with SARS-CoV-2 induced a significant 528 infiltration of macrophages in fLX. We identified infiltrating activated macrophages as the 529 dominant mediator of the prominent type I IFN response observed in infected fLX, as well as the 530 major compartment co-expressing USP18 and ISG15. Finally, we also identified activated 531 macrophages to be the primary carriers of viral RNA. Altogether, our work highlights lung 532 infiltrating macrophages as a multi-faceted hematopoietic subset mediating front-line antiviral 533 responses against SARS-CoV-2 while also safeguarding lung tissue integrity. Our findings 534 provide unique molecular correlates of lung tissue protection during SARS-CoV-2 infection, and 535 propose a unique model in which macrophage-mediated ISG responses would promote a 536 systemic antiviral response against SARS-CoV-2, and tight control of these responses via the 537 USP18-ISG15 axis would prevent excessive inflammation and severe histopathology. 538

Our study suggests a working model (Figure 7) in which lung resident macrophages (e.g. 539 alveolar macrophages) would become locally activated upon detection of SARS-CoV-2 RNA, and 540 activation would promote monocyte infiltration via regulated secretion of specific inflammatory 541 chemokines (CCL2/4/8, CXCL10). Monocyte infiltration would be followed by macrophage 542 differentiation, activation, and polarization toward inflammatory and regulatory phenotypes. These 543 two subsets of macrophages would then promote a systemic antiviral state across the epithelial 544 compartment in a coordinated fashion, enabling rapid suppression of viral spread and replication. 545

The USP18-ISG15 axis would tightly control those responses in order to protect the tissue from 546 excessive inflammation. In contrast, in NRG-L mice, the pro-inflammatory response mediated by 547 resident human macrophages following detection of viral RNA would remain a "call in the dark." See also Figure S7 . Upregulation of the USP18-ISG15 axis allows for a tightly balanced inflammatory response that 887 preserves lung tissue integrity during the antiviral response (4). Imaged by BioRender. 

Ten to fifteen weeks post engraftment, NRG-L and HNFL mice of both sexes were inoculated via 977 intra-fetal lung xenograft (intra-fLX) injection with 10 4 or 10 6 PFU of SARS-CoV-2 in 50 µL of sterile 978 1X PBS. Inoculations were performed under 1-3% isoflurane anesthesia. Either one or both 979 implants were inoculated by direct injection into the fLX. Animals were euthanized at day two or 980 day seven post inoculation. 981

Intranasal inoculation of K18-hACE2 with SARS-CoV-2. 10-12 week old K18-hACE2 mice of 982 both sexes were intranasally inoculated with 10 6 PFU of SARS-CoV-2 in 50 µl of sterile 1X PBS. 983

Inoculations were performed under 1-3% isoflurane anesthesia. Animals were euthanized either 984 prior to infection, at 2DPI, at 7DPI, or when they reached euthanasia criteria (as defined in related 985

Tissue collection and lung inflation for histology. At the indicated endpoints, mice were 987 anesthetized using 1-3% isoflurane, followed by euthanasia using an overdose of 988 ketamine/xylazine. For lung inflation specifically, a midline incision was made to open the 989 abdominal cavity of the mouse. After the diaphragm was punctured, the rib cage was cut from 990 sternum to chin to open the thoracic cavity. Following opening of the rib cage, skin and 991 subcutaneous tissue were removed to expose the trachea, and an 18G catheter was inserted into 992 the trachea and secured with a ligature. The lungs were insufflated with 1.5 mL of low-melt 993 agarose and removed from the mouse after agarose solidification, then placed in 10% NBF for 994 fixation for a minimum of 72 hours. to the flask. The next day, media was removed, the cell monolayer was rinsed with 1X PBS, pH 1006 7.5 (ThermoFisher Scientific) and 25 ml of fresh DMEM containing 2% FBS was added. Two days 1007 later, when the cytopathic effect of the virus was clearly visible, culture medium was collected, 1008 filtered through a 0.22 µm filter, and stored at −80°C. Our P2 working stock of the virus was 1009 prepared by infecting Vero E6 cells with the P1 stock, at a multiplicity of infection (MOI) of 0.1. 1010

Cell culture media was harvested at 2DPI and 3DPI, and after the last harvest, ultracentrifuged 1011 (Beckman Coulter Optima L-100k; SW32 Ti rotor) for 2 h at 25,000 rpm (80,000 x g) over a 20% 1012 sucrose cushion (Sigma-Aldrich). Following centrifugation, the media and sucrose were 1013 discarded, and pellets were left to dry for 5 min at room temperature. Pellets were then 1014 was collected every 24 h for 72 h total. After 72 h, the media was treated with a 5X solution of 1050 40% PEG8000 and 2.5 M NaCl to precipitate the AAV for 2 h at 4°C before being spun down at 1051 4300 x g for 20 min. Cells from plates were scraped, washed with PBS, and resuspended in 1052 hypotonic buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.35 mg/ml spermine) on ice for 10 1053 min before 1 ml restore buffer (62.5% sucrose wt/vol in hypotonic buffer) was added. Cell 1054 membranes were sheared in a 15 ml Kontes dounce homogenizer and nuclei were spun down at 1055 500 x g for 10 min. AAV from PEG precipitate was resuspended in 6 ml high salt buffer (2.5 mM 1056

KCl, 1 mM MgCl2, 1 M NaCl in PBS) and added to nuclei that had been resuspended in 1 ml low 1057 salt buffer (2.5 mM KCl, 1 mM MgCl2, in PBS). Lysate was treated with 250 units of Benzonase 1058 (Sigma) at 37°C for 30 min and then spun at 4300 x g for 30 min before being loaded onto an 1059 iodixanol gradient. AAV was spun at 38,000 rpm in an SW41 rotor for 3 h at 16°C. AAV was 1060 collected from the 40% iodixanol layer and buffer was exchanged to AAV storage buffer (PBS 1061 with 35 mM NaCl, 0.002% pluronic F-68, 5% glycerol) in a 100 MWCO centrifugal filter column 1062 cell subsets were gated as follows: human CD45 + , hCD45 + mCD45 -; human CD3 + , hCD45 + 1148 hCD3 + ; human CD4 + , hCD45 + hCD3 + hCD4 + ; human CD8 + , hCD45 + hCD3 + hCD8 + ; CD20 + , 1149 hCD45 + hCD3 -hCD20 + ; human CD56 + , hCD45 + hCD3 -hCD20 -hCD33 -hCD56+. + . One-Step RT-qPCR using Applied Biosystems QuantStudio 3 (ThermoFisher Scientific), with the 1159 following cycling conditions; reverse transcription for 10 min at 55°C and denaturation at 94°C for 1160 3 min followed by 45 cycles of denaturation at 94°C for 15 sec and annealing/extension at 58°C 1161 for 30 sec. Ct values were determined using QuantStudio TM Design and Analysis software V1.5.1. 1162

Calculations for RNA copies/mL were determined using a SARS-CoV-2 E RNA as a standard. 1163

infected fLX were quantified by plaque assay. After euthanizing mice, tissues were collected in 1165 500 µL of RNAlater (MilliporeSigma: # R0901500ML) and stored at -80°C. The day prior to 1166 experiments, 8x10 4 cells per well were seeded in a 24-well plate. Between 20 and 30 mg of tissue 1167 was placed into 500 µL of OptiMEM (ThermoFisher Scientific). Tissues were homogenized using 1168 a Qiagen TissueLyser II (Qiagen) by two dissociation cycles (two min at 1800 oscillations/min) 1169 with one min rest in between. Samples were then subjected to centrifugation at 13,000 rpm for 10 1170 min at room temperature, and supernatant was transferred to a new 1.5 mL tube. From this, 1:10 2 1171 separated over an EASY-Spray column, (ES803A, ThermoFisher Scientific) using a gradient (6% 1274 to 19% over 58 min, then 19% to 36% over 34 min) of mobile phase B (0.1% formic acid, 80% 1275 acetonitrile) at a flowrate of 250 nL/min. The mass spectrometer was operated in positive ion 1276 mode with a capillary temperature of 275°C and a spray voltage of 2500 V. All data was acquired 1277 with the mass spectrometer operating in data dependent acquisition (DDA) mode, with FAIMS 1278 cycling through one of three compensation voltages (-50V, -57V, -64V) at each full scan. 

Host transcript frequencies (A; human, mouse, and SARS-CoV-2) and SARS-CoV-2 gene 1509 counts (B) in naïve fLX (n=4), as well as in 2DPI (n=4), 7DPI (n=8) and contralateral fLX (n=3) 1510 used for bulk transcriptomic

PCA plots of 2DPI (left; n=4), 7DPI (middle; n=6) and contralateral (right; n=3) samples vs. 1512 naïve samples following bulk transcriptomic analysis

Number of downregulated (left) and up-regulated (right) transcripts overlapping or not between 1514 2DPI (n=4), 7DPI (n=6) and contralateral (n=3) fLX samples

Normalized count of IFNB1 and IFNL1 transcripts in naïve

contralateral (n=3) fLX samples. Adjusted p-values in comparison to naïve fLX are indicated

Cluster heatmap representing protein up-(z-score>0) and downregulated (z-Score<0) in NRG-1518

L fLX at 7DPI (n=7, 10 6 PFU of SARS-CoV-2) in comparison to naïve fLX (n=5)

Cluster heatmap representing protein up-(z-score>0) and downregulated (z-Score<0

L fLX at 7DPI (n=7, 10 6 PFU of SARS-CoV-2) in comparison to 2DPI (n=4) fLX

Protein pathway enrichment analysis at 7DPI in comparison to naïve fLX. Level of enrichment 1522 for each protein pathway is colored coded

Related to Figure 3. Phospho-proteomic characterization of SARS-CoV-2 1525 infection in NRG-L mice

Cluster heatmap representing proteins with up-(z-score>0) and down-phosphorylation

NRG-L fLX at 2DPI (A; n=4) and at 7DPI (B; n=7) (10 6 PFU of SARS-CoV-2)

Volcano plots displaying differentially phosphorylated proteins at 2DPI (C, n=4) and 7DPI

D, n=7) in inoculated fLX of NRG-L mice in comparison to naïve (n=5) fLX. Proteins with p≤0.05 1531 (horizontal dashed line) and with logFC≥1 or ≤-1 (vertical dashed lines) are considered 1532 significantly up-or downregulated respectively

Protein pathway enrichment analysis at 2DPI (E; n=4) and 7DPI (F; n=7) in comparison to 1534 naïve fLX (n=3)

Related to Figure 5 and 6. Characterization of SARS-CoV-2 infection in HNFL 1537 mice

A. t-SNE plots displaying clustered expression (scaled expression) of several transcripts coding 1539 for several human myeloid, inflammatory, and regulatory markers (CD33, CD14, CD68

Cluster defining genes (i.e. whose expression level is significantly 1541 associated with a given cluster) have their name followed with an asterisk

Volcano plots displaying differentially expressed proteins in naïve HNFL (n=4) vs. NRG-L (n=4)

fLX following side-by-side analysis by mass spectrometry run. Proteins with p≤0.05 (horizontal 1545 dashed line) and with logFC≥1 or ≤-1 (vertical dashed lines) are considered significantly up-or 1546 downregulated respectively

Quantification of tissue area immunoreactive for CD68 (% of analyzed tissue) using Halo Image 1548 analysis in naïve fLX from HNFL and NRG-L mice. n=3-8. Mean±SD, Welch's t test ****p≤0

CoV-2 viral RNA quantification by RT-qPCR in inoculated fLX of NRG-L or NRGF-L

Limit 1551 of detection is showed as a dotted line (LOD) and represent mean viral load (n=7) in naïve fLX 1552 extracted from NRG-L and NRGF-L mice. Mean±SEM, Kruskal-Wallis test

Histopathologic score of four selected specific histopathological manifestations observed in 1554

n=8-12) and HNFL (n=4) fLX inoculated with 10 6 PFU of SARS-CoV-2 at 2DPI and 7DPI

Sum of all the histopathologic score recorded for each fLX analyzed was used to calculate 1556 cumulative histopathologic score shown in Figure 5K. Mean±SEM, two-way ANOVA *p≤0

Gating strategy (Flow cytometry dot plots) used to delineate the human hematopoietic 1559 compartment in naïve and inoculated HNFL fLX

Volcano plots displaying differentially phosphorylated proteins at 2DPI in inoculated fLX of 1561 NRG-L mice (F) and HNFL mice (G) following side-by-side sample analysis by mass 1562 spectrometry. Proteins with p≤0.05 (horizontal dashed line) and with logFC≥1 or ≤-1 (vertical 1563 dashed lines) are considered significantly up-or downregulated respectively

Significantly (p≤0.05) differentially expressed transcripts (upregulated, red; downregulated

Fold changes were derived from single-cell RNAseq 1568 datasets and were computed using MAST. Transcripts with p≤10 -100 (horizontal dotted line) and 1569 with log2 fold change≥0

t-SNE plots displaying clustered expression (scaled expression) of several transcripts coding 1571 for human cell surface markers, cytokines and ISGs in the human compartment of HNFL fLX at 1572

7DPI (J) and at 2DPI (K). (J) Myeloid, inflammatory, and regulatory markers expression

ISG expression (OAS1-2, MX2, DDX58 1574 and IFI44L) in inoculated HNFL fLX at 2DPI. Cluster of interest are indicated with a dotted circle, 1575 and each cluster name is indicated at the left of each panel (AIM, activated inflammatory 1576 macrophages; ARM, activated regulatory macrophages; SSM, steady-state macrophages; DC, 1577 dendritic cells; Fib, fibroblasts; Mon, monocytes)

Vascular Disease and Thrombosis in SARS-CoV-2-1602 Infected Rhesus Macaques

STAT2 is an essential adaptor in USP18-mediated suppression 1605 of type I interferon signaling

Autoantibodies against type I IFNs in patients 1608 with life-threatening COVID-19

USP18-a multifunctional component in the 1610 interferon response

Imbalanced Host Response to SARS-CoV-2 Drives 1613 Development of COVID-19

STAT2 signaling restricts 1616 viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Monocytes and macrophages, targets of SARS-CoV-2: the clue 1620 for Covid-19 immunoparalysis. bioRxiv

Fatal neuroinvasion of SARS-CoV-2 1623 in K18-hACE2 mice is partially dependent on hACE2 expression

Global absence and targeting of protective immune 1626 states in severe COVID-19

SARS-CoV-2 evades immune 1629 detection in alveolar macrophages

COVID-19 tissue 1632 atlases reveal SARS-CoV-2 pathology and cellular targets

The use of humanized mice for studies of viral pathogenesis 1634 and immunity

Selective expansion of myeloid and NK cells in 1637 humanized mice yields human-like vaccine responses

MAST: a flexible statistical framework for assessing 1640 transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

Circuits between infected 1644 macrophages and T cells in SARS-CoV-2 pneumonia

Impaired type I interferon activity and 1647 inflammatory responses in severe COVID-19 patients

Multiple functions of 1649 USP18

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human 1652 Angiotensin-Converting Enzyme 2

Selective inactivation of USP18 isopeptidase 1655 activity in vivo enhances ISG15 conjugation and viral resistance

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Causal analysis approaches 1661 in Ingenuity Pathway Analysis

Morphometry of 1663 SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures

R2-P2 rapid-robotic 1666 phosphoproteomics enables multidimensional cell signaling studies

Clinical features of familial 1668 clustering in patients infected with 2019 novel coronavirus in

Delayed production of neutralizing antibodies correlates with fatal COVID-1672 19

Increased complement activation is a distinctive feature 1675 of severe SARS-CoV-2 infection

Coagulation 1677 Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic 1678 Viruses

UBP43 is a novel regulator of interferon signaling independent of its ISG15 1681 isopeptidase activity

The multiple faces of CCL13 in immunity 1683 and inflammation

Pathological inflammation in patients with COVID-19: a key 1685 role for monocytes and macrophages

Asymptomatic SARS 1687 Coronavirus 2 infection: Invisible yet invincible

Humanized Mice for Live-Attenuated Vaccine Research: 1689 From Unmet Potential to New Promises. Vaccines (Basel) 8

The PRIDE database and related 1692 tools and resources in 2019: improving support for quantification data

ISG15 in antiviral immunity and beyond

The spatial landscape of lung pathology during COVID-19 1698 progression

Human hemato-lymphoid system mice: current use and future potential for medicine

The chemokine 1703 CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum

Host transcription factor 1706 Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for 1707 viral persistence

Pathogenesis and transmission of SARS-CoV-2 in 1710 golden hamsters

Responses to acute infection with 1713 SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets

ISG15 deficiency and increased viral resistance in 1716 humans but not mice

Sp100 provides intrinsic immunity against 1718 human papillomavirus infection

Ad26 vaccine protects against SARS-CoV-2 1721 severe clinical disease in hamsters

Immunology of COVID-19: Current State of the Science

BNT162b vaccines protect rhesus macaques from SARS-1727 CoV-2

Precision mouse models with expanded 1730 tropism for human pathogens

SARS-CoV-2 infection is effectively treated 1733 and prevented by EIDD-2801

A Bayesian model to perform bi-clustering of genes into modules and cells into 1736 subpopulations using single-cell RNA-seq data. bioRxiv

Discriminating mild from critical 1739 COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

SARS-CoV-2 infection of human ACE2-transgenic mice 1743 causes severe lung inflammation and impaired function

Characteristics of and Important Lessons From the 1745

COVID-19) Outbreak in China: Summary of a Report of 72314 Cases 1746 From the Chinese Center for Disease Control and Prevention

A nanoluciferase SARS-CoV-2 for rapid 1749 neutralization testing and screening of anti-infective drugs for COVID-19

Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected 1752

Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation

Decontamination of ambient RNA in single-cell RNA-seq with DecontX

Human intracellular ISG15 prevents interferon-1759 alpha/beta over-amplification and auto-inflammation

COVID-19 treatments and 1762 pathogenesis including anosmia in K18-hACE2 mice

A Novel Coronavirus from Patients with Pneumonia in China

tissues were placed on a 60 mm dish and minced using a disposable scalpel. Tissue pieces were 1076 transferred to a 15 mL conical tube with 3 mL of digestion buffer (HBSS minus Ca 2+ , Mg 2+ , and 1077 phenol red, 0.5 mg/mL Liberase TM, 1 mg/mL DNase I) and incubated at 37°C for 30 min with 1078 agitation every 10 min. Minced pieces were transferred to a 70 µm strainer on a 50 mL tube and 1079 mashed through using the plunger of a 3 mL syringe plunger. The strainer was washed two times 1080 with 1 mL of FACS buffer (1X PBS with 1% (v/v) FBS) and the cell suspension was centrifuged 1081at 300 x g for 5 min at 4°C. The cell pellet was resuspended in 1 mL of ACK lysing buffer 1082 (ThermoFisher Scientific; #A1049201) and incubated for 2 min at room temperature. After 1083 incubation, 9 mL of FACS buffer was added to quench the lysis, samples were centrifuged at 300 1084x g for 5 min at 4°C, and the cell pellet was resuspended in 1 mL of FACS buffer prior to antibody 1085 staining. 1086Single cell suspension from spleen. Spleen was collected and placed in RPMI with 10% FBS. 1087To generate single cell suspensions, a 70 µm strainer was placed into one well of a 6-well plate 1088 with 4 mL of FACS buffer. Whole spleen was then placed onto the strainer and mashed through 1089 the strainer using a 3 mL syringe plunger. After the strainer was washed twice with 1 mL of FACS 1090 buffer, the resultant single cell suspension was transferred to a 15 mL conical tube and samples 1091 were centrifuged at 300 x g for 5 min at 4°C. The cell pellet was resuspended in 1 mL of ACK 1092 lysing buffer and incubated for 2 min at room temperature. After incubation, 9 mL of FACS buffer 1093 was added to quench the lysis, samples were centrifuged at 300 x g for 5 min at 4°C, and the cell 1094 pellet was resuspended in 1 mL of FACS buffer. 1095 1096

Generation of cell lysates for total RNA extractions. Tissues were collected from mice and 1098 placed in 600 µL of RNAlater (MilliporeSigma: #R0901500ML) and stored at -80°C. For 1099 processing, 20-30 mg of tissue was taken and placed into a 2 mL tube with 600 µL of RLT buffer 1100 with 1% β-mercaptoethanol and a 5 mm stainless steel bead (Qiagen, Hilden, Germany: #69989). 1101Tissues were then dissociated using a Qiagen TissueLyser II (Qiagen) with the following cycle: 1102 two min dissociation at 1800 oscillations/min, one min rest, two min dissociation at 180 1103 oscillations/min. Samples were then subject to centrifugation at 13,000 rpm for 10 min at room 1104 temperature and supernatant was transferred to a new 1.5 mL tube. RNA extractions were 1105 performed using a Qiagen RNeasy Plus Mini Kit (Qiagen: #74134), according to the 1106 manufacturer's instructions, with an additional on-column DNase treatment (Qiagen: #79256). 1107 RNA was eluted in 30 µL of RNase/DNase free water. 1108 RNA extraction from serum. Viral RNA was extracted from serum using a Zymo Viral RNA 1109 extraction kit (Zymo Research, Irvine, CA, USA: #R1035) following the manufacturers protocol. 1110Briefly, serum was mixed with RNA/DNA shield (Zymo) at a 1:1 ratio. RNA buffer was then added 1111 to the serum (2:1 ratio) and passed through a column by centrifugation at 13,000 x g. The column 1112 was then washed twice, and RNA was eluted with 15 µL of RNase/DNase free water. 1113 1114

For all flow cytometry experiments, flowcytometric analysis was performed using an LSRII Flow 1116Cytometer (BD Biosciences). Flow cytometry fluorophore compensation for antibodies was 1117 performed using an AbC™ Anti-Mouse Bead Kit (ThermoFisher Scientific). Flow cytometry data 1118 were analyzed using FlowJo software (TreeStar, Ashland, OR, USA). Buffer, cells were fixed with fixation buffer for 30 min at 4°C in the dark. Human immune cell 1133 subsets from naïve NRG-L fLX were gated as follows: Human CD45 + , human CD45 + murine 1134 CD45 -; T-cells, CD45 + CD3 + ; CD11c/CD33, CD45 + CD3 -CD19 -CD33 + CD11c + ; CD56, CD45 + 1135 CD3 -CD19 -CD56 + . 1136 Antibody staining and flow-cytometry analysis of HFNL fLX. After generation of single cell 1137 suspension, 5x10 5 -1x10 6 cells were used for flow cytometry staining. Cells were centrifuged at 1138 300 X g for 5 min at 4°C. The cell pellet was resuspended in a mix of 22.5 µL FACS buffer and 1139 2.5 µL of FcX (Biolegend; #422302) and incubated for 10 min at room temperature. After blocking, 1140 25 µL of antibody cocktail targeting hCD3, hCD20, hCD16, hHLA-DR, hCD45, hCD8, hCD4, 1141 hCD33, hCD45RA, hCD56, hCD14, mCD45, and containing a LIVE/DEAD viability dye 1142 (ThermoFisher Scientific) was added to each sample and incubated in the dark for 30 min at 4°C. 1143

After staining, 1 mL of FACS buffer was added to each sample, samples were centrifuged at 300 1144x g for 5 min, washed with 1 mL FACS buffer, centrifuged at 300 x g for 5 min, and then fixed in 1145 -1:10 7 dilutions were made in OptiMEM and 200 µL of each dilution were plated onto a 24-well 1172 plate. Supernatant was incubated at 37°C for 1 h with gentle rocking of the plate every 10 min. 1173After viral adsorption, 1 mL a 1:1 mixture of 2X DMEM 4% FBS and 2.4% Avicel (Dupont) was 1174 overlaid into each well. Plates were incubated for 72 h at 37°C with 5% CO2. Avicel was then 1175 removed, cells were washed twice with 1X PBS, and then cells were fixed in 10% buffered 1176 formalin (ThermoFisher Scientific) for 1 h. After fixation, formalin was removed, and cells were 1177 stained with 0.1% crystalline violet in 10% ethanol/water for 1 h and washed with tap water. 1178Number of plaques were counted, and infectious particles (PFU/mg of tissue) were calculated. 1179 1180

Histologic processing and analysis. Tissue samples were fixed for 72 h in 10% neutral buffered 1182 formalin, processed in a Tissue-Tek VIP-5 automated vacuum infiltration processor (Sakura 1183Finetek USA, Torrance, CA, USA), followed by paraffin embedding using a HistoCore Arcadia was examined at 200x with a DM2500 light microscope (Leica) using the following criteria: 0 = 1195 not present, 1 = found in <5% of fields, 2 = found in >5% but <25% of fields, or 3 = found in >25% 1196 of fields. Several criteria were also restricted to 'not observed' (0) or 'observed' (1). Scores were 1197 combined to generate a cumulative lung injury score. 1198Multispectral fluorescent imaging. Fluorescently labeled slides were imaged using either a 1199 Mantra 2.0 TM or Vectra Polaris TM Quantitative Pathology Imaging System (Akoya Biosciences). To 1200 maximize signal-to-noise ratios, fluorescently acquired images were spectrally unmixed using a 1201 synthetic library specific for the Opal fluorophores used in each assay plus DAPI. An unstained 1202 fLX section was used to create an autofluorescence signature that was subsequently removed 1203 from multispectral images using InForm software version 2.4.8 (Akoya Biosciences). spectrometer was interfaced to the Easy nanoLC1200 HPLC system (ThermoFisher Scientific). 1271Briefly, the peptides were first loaded onto a reverse-phase nanotrap column in mobile phase A, 1272(75 mm i.d. 3 2 cm, Acclaim PepMap100 C18 3 mm, 100 A°, ThermoFisher Scientific) andAndromeda score of 40 and a threshold delta score of 8 was applied to phosphopeptides. The 1300MaxQuant output files designated ''Phospho(STY)sites'' and ''proteinGroups'' were filtered to 1301 remove entries that were either entirely mouse, or in the case of completely homologous peptides, 1302 had annotations of both mouse and human. These two files, filtered to contain only accessions 1303 related to human proteins, were used for data normalization and other statistical analysis using 1304 in-house generated scripts in the R environment. 1305Bulk RNA sequencing. Total RNA was processed from fLX as described above, and sent to BGI 1306 genomics (Hong Kong, China) for library preparation and sequencing (Pair-ends, 100 bp, 20M 1307 reads per sample). Raw FASTQ files were quality-checked with FastQC v0.11.7. Reads were 1308 found to be excellent quality and were aligned to the combined human (GRCh38, Ensembl 101) 1309 and mouse (GRCm38, Ensembl 101) genomes with STAR v2.7.1a followed by quantification with 1310 featureCounts v1.6.2. Quality was checked with MultiQC v1.6. All samples passed quality 1311 thresholds of >75% sequences aligned and >15 million aligned reads per sample. Significantly 1312 up-and downregulated genes were identified with DESeq2 v1.23.10 in R v3.6.0. Three treatment 1313 groups were compared to uninfected samples in turn: 2DPI, 7DPI and 7DPI contralateral. P-1314 values were FDR-adjusted, and log 2 fold change was shrunk with the apeglm method. A. Histopathologic score of ten specific histopathological manifestations observed in fLX 1471 inoculated with 10 4 or 10 6 PFU of SARS-CoV-2 at 2DPI and 7DPI. Sum of the ten score for each 1472 mouse was used to calculate cumulative histopathologic score shown in Figure 2A . n=5-10 fLX. 1473 mean±SEM, two-way ANOVA *p≤0.05, **p≤0.01. 1474 B. Histopathologic score of ten specific histopathological manifestations observed in fLX 1475 inoculated with 10 6 PFU of SARS-CoV-2 at 2DPI and 7DPI in comparison to naïve/Contralateral 1476 (CL) fLX. Sum of the ten score for each mouse was used to calculate cumulative histopathologic 1477 score shown in Figure 2B . n=8-12 fLX. mean±SEM, Kruskal-Wallis test *p≤0.05, **p≤0.01, 1478 ***p≤0.001.